An optimized integrin α6-targeted peptide for positron emission tomography/magnetic resonance imaging of pancreatic cancer and its precancerous lesion

Affiliations

• ¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
• ² School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
• ³ Experimental Equipment Management Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
• ⁴ Central Research Institute UIH Group, Shanghai, China.